Loading...
Projects / Programmes
Novel engineered protein nanoparticles to combat drug-resistant infections: oligolysins
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 4.06.00 | Biotechnical sciences | Biotechnology |
| Code | Science | Field |
|---|---|---|
| 3.04 | Medical and Health Sciences | Medical biotechnology |
Evaluation
(metodology)
Points
322.75
A''
73.92
A'
203.46
A1/2
256.06
CI10
418
CImax
51
h10
12
A1
1.22
A3
0
Data for the last 5 years (citations for the last 10 years) on
March 27, 2026;
Data for score A3 calculation refer to period
2020-2024
Data for ARIS tenders (
04.04.2019 – Programme tender,
archive
)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
| Database | Linked records | Citations | Pure citations | Average pure citations |
|---|---|---|---|---|
| WoS | 29 | 530 | 387 | 13.34 |
| Scopus | 29 | 562 | 415 | 14.31 |
Organisations (3) , Researchers (1)
3030 Center of Excellence for Biosensors, Instrumentation and process Control
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 50490 | Pharmacy | Head | 2026 | 65 |
0787 University of Ljubljana, Faculty of Pharmacy
8724 Sferogen, innovative biotech LLC